Trial intelligence / Profile preview

Etomidate versus ketamine for emergency intubation in sepsis patients

TCTR20210213001Phase 3Recruiting

Sponsor
Thammasat University
Start
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of etomidate, ketamine in sepsis, sponsored by Thammasat University. Started Feb 2019; status: recruiting.

02

Drugs

etomidateketamine
03

Conditions

sepsis

Beyond the preview

Go deeper on TCTR20210213001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210213001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call